LA JOLLA, Calif.–(BUSINESS WIRE)– #Biotech–AeroRx Presents Positive Phase 2a Data for Inhaled AERO-007, the First Potential Nebulized LABA+LAMA Fixed-Dose Combination in Development for COPD
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
